Annovis Bio, Inc.: Annovis Bio to Present at Jefferies Virtual Healthcare Conference 2021
Berwyn, Pennsylvania (Newsfile Corp. - June 3, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ( Annovis or the Company ), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced CEO Maria L. Maccecchini will present at the Jefferies Virtual Healthcare Conference 2021 as follows:
Date: Friday, June 4, 2021
Time: 8:00 a.m. ET
Webcast: https://wsw.com/webcast/jeff174/anvs/1866024
The presentation will be webcast live and archived for 30 days thereafter.
About Annovis Bio Inc.
Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer s disease (AD), Parkinson s disease (PD) and Alzheimer s in Down Syndrome (AD-DS). We believe that we are the only company developing a drug for AD, PD and AD-DS t
Annovis Bio to Present at Jefferies Virtual Healthcare Conference 2021 yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Constellation Pharmaceuticals Inc (NASDAQ: CNST) is trading higher Wednesday morning after an announcement that MorphoSys AG (NASDAQ: MOR) will acquire the .
RALEIGH, NC / ACCESSWIRE / June 1, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that John Temperato, CEO